Latest filing published 22 Sept 2022 for 金石亚药.
魏宝康: trading record in brief
魏宝康 is a declared insider of 金石亚药 (chief executive), with filings sourced from SSE / SZSE (CSRC). The record holds 2 filings, for trades running from 13 January 2022 to 22 September 2022.
Both buying and selling appear: 1 purchase worth €121k, against 1 sale worth €15k. The net balance comes to €106k on the buying side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
Most recently, on 22 September 2022, the filings show an open-market purchase worth €121k in 金石亚药. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to 魏宝康
Open company profiles for insider transactions, fundamentals and analyst consensus when available.